272 related articles for article (PubMed ID: 27358461)
21. Dissecting the Molecular Pathway Involved in PLK2 Kinase-mediated α-Synuclein-selective Autophagic Degradation.
Dahmene M; Bérard M; Oueslati A
J Biol Chem; 2017 Mar; 292(9):3919-3928. PubMed ID: 28154193
[TBL] [Abstract][Full Text] [Related]
22. Phosphorylation at S87 is enhanced in synucleinopathies, inhibits alpha-synuclein oligomerization, and influences synuclein-membrane interactions.
Paleologou KE; Oueslati A; Shakked G; Rospigliosi CC; Kim HY; Lamberto GR; Fernandez CO; Schmid A; Chegini F; Gai WP; Chiappe D; Moniatte M; Schneider BL; Aebischer P; Eliezer D; Zweckstetter M; Masliah E; Lashuel HA
J Neurosci; 2010 Mar; 30(9):3184-98. PubMed ID: 20203178
[TBL] [Abstract][Full Text] [Related]
23. CK1BP Reduces α-Synuclein Oligomerization and Aggregation Independent of Serine 129 Phosphorylation.
Elsholz L; Wasser Y; Ziegler P; Habib P; Voigt A
Cells; 2021 Oct; 10(11):. PubMed ID: 34831053
[TBL] [Abstract][Full Text] [Related]
24. Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease.
Spencer B; Trinh I; Rockenstein E; Mante M; Florio J; Adame A; El-Agnaf OMA; Kim C; Masliah E; Rissman RA
Neurobiol Dis; 2019 Jul; 127():163-177. PubMed ID: 30849508
[TBL] [Abstract][Full Text] [Related]
25. Phosphorylation of α-Synuclein at Y125 and S129 alters its metal binding properties: implications for understanding the role of α-Synuclein in the pathogenesis of Parkinson's Disease and related disorders.
Lu Y; Prudent M; Fauvet B; Lashuel HA; Girault HH
ACS Chem Neurosci; 2011 Nov; 2(11):667-75. PubMed ID: 22860160
[TBL] [Abstract][Full Text] [Related]
26. GSK-3β dysregulation contributes to parkinson's-like pathophysiology with associated region-specific phosphorylation and accumulation of tau and α-synuclein.
Credle JJ; George JL; Wills J; Duka V; Shah K; Lee YC; Rodriguez O; Simkins T; Winter M; Moechars D; Steckler T; Goudreau J; Finkelstein DI; Sidhu A
Cell Death Differ; 2015 May; 22(5):838-51. PubMed ID: 25394490
[TBL] [Abstract][Full Text] [Related]
27. Implication of Alpha-Synuclein Phosphorylation at S129 in Synucleinopathies: What Have We Learned in the Last Decade?
Oueslati A
J Parkinsons Dis; 2016; 6(1):39-51. PubMed ID: 27003784
[TBL] [Abstract][Full Text] [Related]
28. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
[TBL] [Abstract][Full Text] [Related]
29. A Focus on the Beneficial Effects of Alpha Synuclein and a Re-Appraisal of Synucleinopathies.
Ryskalin L; Busceti CL; Limanaqi F; Biagioni F; Gambardella S; Fornai F
Curr Protein Pept Sci; 2018; 19(6):598-611. PubMed ID: 29150919
[TBL] [Abstract][Full Text] [Related]
30. Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.
Eschbach J; von Einem B; Müller K; Bayer H; Scheffold A; Morrison BE; Rudolph KL; Thal DR; Witting A; Weydt P; Otto M; Fauler M; Liss B; McLean PJ; Spada AR; Ludolph AC; Weishaupt JH; Danzer KM
Ann Neurol; 2015 Jan; 77(1):15-32. PubMed ID: 25363075
[TBL] [Abstract][Full Text] [Related]
31. Decreased expression of serum- and glucocorticoid-inducible kinase 1 (SGK1) promotes alpha-synuclein increase related with down-regulation of dopaminergic cell in the Substantia Nigra of chronic MPTP-induced Parkinsonism mice and in SH-SY5Y cells.
Yeo S; Sung B; Hong YM; van den Noort M; Bosch P; Lee SH; Song J; Park SK; Lim S
Gene; 2018 Jun; 661():189-195. PubMed ID: 29604467
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein arginylation in the human brain.
Zhao J; Pan B; Fina M; Huang Y; Shimogawa M; Luk KC; Rhoades E; Petersson EJ; Dong DW; Kashina A
Transl Neurodegener; 2022 Apr; 11(1):20. PubMed ID: 35395956
[TBL] [Abstract][Full Text] [Related]
33. Systemic exosomal siRNA delivery reduced alpha-synuclein aggregates in brains of transgenic mice.
Cooper JM; Wiklander PB; Nordin JZ; Al-Shawi R; Wood MJ; Vithlani M; Schapira AH; Simons JP; El-Andaloussi S; Alvarez-Erviti L
Mov Disord; 2014 Oct; 29(12):1476-85. PubMed ID: 25112864
[TBL] [Abstract][Full Text] [Related]
34. Fatty Acid Binding Protein 3 Enhances the Spreading and Toxicity of α-Synuclein in Mouse Brain.
Yabuki Y; Matsuo K; Kawahata I; Fukui N; Mizobata T; Kawata Y; Owada Y; Shioda N; Fukunaga K
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210174
[TBL] [Abstract][Full Text] [Related]
35. Cystatin C as a potential therapeutic mediator against Parkinson's disease via VEGF-induced angiogenesis and enhanced neuronal autophagy in neurovascular units.
Zou J; Chen Z; Wei X; Chen Z; Fu Y; Yang X; Chen D; Wang R; Jenner P; Lu JH; Li M; Zhang Z; Tang B; Jin K; Wang Q
Cell Death Dis; 2017 Jun; 8(6):e2854. PubMed ID: 28569795
[TBL] [Abstract][Full Text] [Related]
36. Identification of a specific α-synuclein peptide (α-Syn 29-40) capable of eliciting microglial superoxide production to damage dopaminergic neurons.
Wang S; Chu CH; Guo M; Jiang L; Nie H; Zhang W; Wilson B; Yang L; Stewart T; Hong JS; Zhang J
J Neuroinflammation; 2016 Jun; 13(1):158. PubMed ID: 27329107
[TBL] [Abstract][Full Text] [Related]
37. α-Synuclein protects against manganese neurotoxic insult during the early stages of exposure in a dopaminergic cell model of Parkinson's disease.
Harischandra DS; Jin H; Anantharam V; Kanthasamy A; Kanthasamy AG
Toxicol Sci; 2015 Feb; 143(2):454-68. PubMed ID: 25416158
[TBL] [Abstract][Full Text] [Related]
38. Efficient modification of alpha-synuclein serine 129 by protein kinase CK1 requires phosphorylation of tyrosine 125 as a priming event.
Kosten J; Binolfi A; Stuiver M; Verzini S; Theillet FX; Bekei B; van Rossum M; Selenko P
ACS Chem Neurosci; 2014 Dec; 5(12):1203-8. PubMed ID: 25320964
[TBL] [Abstract][Full Text] [Related]
39. Alpha-synuclein interferes with cAMP/PKA-dependent upregulation of dopamine β-hydroxylase and is associated with abnormal adaptive responses to immobilization stress.
Kim S; Park JM; Moon J; Choi HJ
Exp Neurol; 2014 Feb; 252():63-74. PubMed ID: 24252179
[TBL] [Abstract][Full Text] [Related]
40. Chromatin-Bound Oxidized α-Synuclein Causes Strand Breaks in Neuronal Genomes in in vitro Models of Parkinson's Disease.
Vasquez V; Mitra J; Hegde PM; Pandey A; Sengupta S; Mitra S; Rao KS; Hegde ML
J Alzheimers Dis; 2017; 60(s1):S133-S150. PubMed ID: 28731447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
